• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
CommentaryTech

I lead one of the startups accusing Apple of patent infringement. Here’s why Congress should side with us

By
Priya Abani
Priya Abani
Down Arrow Button Icon
By
Priya Abani
Priya Abani
Down Arrow Button Icon
April 9, 2024, 11:45 AM ET
The International Trade Commission has ruled that some Apple Watch models violate patents.
The International Trade Commission has ruled that some Apple Watch models violate patents.Jeenah Moon - Bloomberg - Getty Images

When I became CEO of AliveCor, a health tech startup dedicated to heart health, little did I know that we would spend years engaged in a legal fight to protect our intellectual property from one of the largest companies in the world. But our David vs. Goliath battle against Apple has even reached President Joe Biden’s desk–and, now, the halls of Congress.

Some people ask me why we haven’t given up, given Apple’s massive war chest and well-documented history of copying other firms’ ideas. As The Washington Post once reported, “Some apps have simply buckled under the pressure.”

But this isn’t just about us. It’s about the entire tech ecosystem. It’s a question of whether startups–and small businesses of all kinds–can stand up for their rights and win. And because we focus specifically on health tech, it’s no exaggeration to say that when it comes to technologies developed by companies like ours, lives hang in the balance.

Here’s what the case is all about, in a nutshell. AliveCor pioneered electrocardiogram technologies (ECG) for smartphones and smartwatches. In 2016 we launched KardiaBand, an FDA-cleared, medical-grade wearable ECG. The responses were wonderful, with people saying it helped to transform their health and their lives. But two years later, Apple announced that it had created its own technology–and made its new watches incompatible with a central feature of KardiaBand.

Equipped with patents, scientific reports, and other evidence, we fought back. Since then, Apple has tried all sorts of maneuvers to fend us off, including bombarding us with expensive litigation. Nevertheless, we’ve been winning before the International Trade Commission (ITC). The agency’s role includes investigating and making determinations involving intellectual property (IP) rights in such cases.

The ITC found Apple to be in violation of the IP protecting our vital heart monitoring technology. As a result, the commission ultimately called for a ban on Apple importing its infringing watches into the United States. The corporate behemoth tried to get President Biden to veto that ban, but fortunately, he declined to do so.

We’re not alone in this kind of fight. Another medical technology company, Masimo, has been engaged in a similar battle, and also won before the ITC. Again, Biden refused to veto an Apple Watch import ban.

But rather than attempt to rectify its wrongs, Apple is trying to use its lobbying power to change the ITC. The company is lobbying Congress to “make some patent owners ineligible to bring complaints before the ITC,” and seeking “to influence the language of committee reports that could affect how the agency levels punishments.”

Apple is also trying another desperate, last-ditch effort. It got the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board to invalidate some of our patents, but we’re confident that our appeal will reverse that decision.

Apple is attempting to argue that an ITC ban on Apple Watch imports would deprive people of a device that is crucial to their health. However, the commission has previously dismissed this argument as inaccurate. In fact, the opposite is true: Allowing Apple to get away with continued infringement will kill innovation and endanger people’s health.

Health tech startups rely on investor funding to save lives. People are willing to invest in these new ideas because they expect that some will succeed, so they’ll recoup their investments and see a future payoff.

If large corporations can simply copy these technologies, then investors will lose the confidence and incentive to provide funding at various stages. Investors and small business leaders need to know that the rules fairly and reliably protect the Davids in the same way that they protect the Goliaths.

Our battle against Apple has always taken place on an uneven field. The intervention of Congress on Apple’s behalf would make things even worse. President Biden stood up to Apple’s bullying tactics–and Congress should do the same.

Priya Abani is the CEO of AliveCor.

More must-read commentary published by Coins2Day:

  • Glassdoor CEO: ‘Anonymous posts will always stay anonymous’
  • We analyzed 46 years of consumer sentiment data–and found that  today’s ‘vibecession’ is just men starting to feel as bad about the economy as women historically have
  • 90% of homebuyers have historically opted to work with a real estate agent or broker. Here’s why that’s unlikely to change, according to the National Association of Realtors
  • Intel CEO: ‘Our goal is to have at least 50% of the world’s advanced semiconductors produced in the U.S. And Europe by the end of the decade’

The opinions expressed in Coins2Day.com commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of  Coins2Day .

Coins2Day Brainstorm AI returns to San Francisco Dec. 8–9 to convene the smartest people we know—technologists, entrepreneurs, Coins2Day Global 500 executives, investors, policymakers, and the brilliant minds in between—to explore and interrogate the most pressing questions about AI at another pivotal moment. Register here.
About the Author
By Priya Abani
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.